Roche (OTCMKTS:RHHBY) Reaches New 12-Month Low at $29.80

Roche Holding AG (OTCMKTS:RHHBY) reached a new 52-week low on Thursday . The company traded as low as $29.80 and last traded at $30.02, with a volume of 3393938 shares traded. The stock had previously closed at $30.54.

Analysts Set New Price Targets

A number of analysts recently issued reports on RHHBY shares. Argus reissued a “hold” rating on shares of Roche in a research report on Monday, March 4th. Morgan Stanley cut Roche from an “equal weight” rating to an “underweight” rating in a research note on Tuesday, January 16th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, Roche currently has an average rating of “Hold” and an average price target of $40.00.

Roche Stock Performance

The company has a fifty day simple moving average of $31.91 and a two-hundred day simple moving average of $33.62. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. First Horizon Advisors Inc. increased its holdings in shares of Roche by 19.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock worth $75,000 after buying an additional 342 shares in the last quarter. Paradigm Asset Management Co. LLC increased its holdings in Roche by 18.4% during the 3rd quarter. Paradigm Asset Management Co. LLC now owns 5,151 shares of the company’s stock valued at $175,000 after purchasing an additional 800 shares in the last quarter. AlphaMark Advisors LLC acquired a new position in Roche in the first quarter worth $34,000. Wetzel Investment Advisors Inc. acquired a new stake in shares of Roche in the fourth quarter valued at $53,000. Finally, Norman Fields Gottscho Capital Management LLC raised its holdings in shares of Roche by 7.3% in the first quarter. Norman Fields Gottscho Capital Management LLC now owns 24,100 shares of the company’s stock valued at $769,000 after buying an additional 1,650 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.